yep, it is strange and certainly outside of guidance.
The FDA has had the resub-NDA data since Feb. Plenty of time to consider study-022 data points and other data REQUESTED by them.
Have to admit, I am excited.
Ann: Trading Halt , page-8
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)